In the report, titled “Medicare: Lack of Price Transparency May Hamper Hospitals’ Ability to Be Prudent Purchasers of Implantable Medical Devices,” GAO noted there is a lack of transparency when determining the price paid for implantable medical devices and also noted the prices paid for the same device can vary significantly by hospital.
Access MediQuip’s response speaks to the company’s suite of surgical implant management solutions that aim to address the issues identified in the GAO report and “solve the problems facing surgical device implants,” said Prakash Patel, MD, CEO of Access MediQuip, in the release.
“The increasingly high costs with surgical devices coupled with a poor coordination of recalls, off-label use and implant acquisition are drawing increasing scrutiny by many groups,” he said. “The stakes are high for individual patients, hospitals and other surgical facilities, surgeons, health plans and device manufacturers, and in many ways it is one of the final large unmanaged frontiers in healthcare management.”
More Articles Featuring Access MediQuip:
Access MediQuip Reaches 100th Hospital Partner Milestone
Access MediQuip Names Dr. Steven Arnold Chief Medical Officer
5 Tips for Managing Implants Profitably
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
